Crisaborole

Common brands: Eucrisa, Dupixent, Allergy Relief, Allergy Nasal, Envarsus Xr

Top reporter: Pfizer Laboratories Div Pfizer Inc

Phosphodiesterase 4 Inhibitor [EPC]Interleukin-4 Receptor alpha Antagonist [EPC]Corticosteroid [EPC]Calcineurin Inhibitor Immunosuppressant [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
9,465
Total Reports
2,852
Serious Reports
24
Death Reports
30
Reported Reactions
Death Report Ratio: Low (0.25%)

Patient Demographics

Male
2,893
Female
5,448

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Crisaborole.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 1,971
16.0%
2 APPLICATION SITE PAIN 1,416
11.5%
3 BURNING SENSATION 985
8.0%
4 OFF LABEL USE 753
6.1%
5 CONDITION AGGRAVATED 704
5.7%
6 PRURITUS 633
5.2%
7 RASH 606
4.9%
8 PAIN 526
4.3%
9 ECZEMA 451
3.7%
10 DERMATITIS ATOPIC 433
3.5%
11 ERYTHEMA 370
3.0%
12 PRODUCT USE IN UNAPPROVED INDICATION 334
2.7%
13 DRUG HYPERSENSITIVITY 260
2.1%
14 DRY SKIN 256
2.1%
15 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 243
2.0%
16 APPLICATION SITE ERYTHEMA 234
1.9%
17 SKIN BURNING SENSATION 233
1.9%
18 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 219
1.8%
19 PRODUCT USE ISSUE 203
1.7%
20 SKIN EXFOLIATION 180
1.5%
21 URTICARIA 149
1.2%
22 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 146
1.2%
23 HYPERSENSITIVITY 143
1.2%
24 APPLICATION SITE PRURITUS 139
1.1%
25 SKIN DISORDER 139
1.1%
26 TREATMENT FAILURE 123
1.0%
27 PRODUCT DOSE OMISSION ISSUE 119
1.0%
28 EYE IRRITATION 108
0.9%
29 DISCOMFORT 107
0.9%
30 DERMATITIS 106
0.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.